Last reviewed · How we verify
NCT04011072
Far Infrared Therapy on Arteriovenous Fistulas in Hemodialysis Patients
NA trial testing Far infrared radiation in Arterio-venous Fistula in 206 participants. Completed in 29 August 2023.
29 August 2023
Quick facts
| Lead sponsor | Herlev and Gentofte Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 206 |
| Start date | 3 October 2019 |
| Primary completion | 29 August 2023 |
| Estimated completion | 29 August 2023 |
| Sites | 9 locations across Denmark |
Drugs / interventions tested
- Far infrared radiation
Conditions studied
- Arterio-venous Fistula — all drugs for Arterio-venous Fistula →
Sponsor
Herlev and Gentofte Hospital
Who can join
18 and older, any sex, with Arterio-venous Fistula. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The number of hemodialysis patients in the world are increasing. In order to receive a sufficient dialysis, the patients needs a well functioning and stable vascular access - preferably an arteriovenous fistula (AVF). Unfortunately, the AVF has a high incidence of stenosis with percutaneous trans luminal angioplasty (PTA) as the only treatment option and a short lifetime. Little do we know of how to improve the survival of the AVF. With this study we want to explore the effect of far infrared therapy on the stenosis, maturation and survival of the arteriovenous fistula. The investigators will divide the patients into 2 groups: A treatment group and a control group. The treatment group will receive infrared therapy on their fistula during their dialysis session. The control group will not receive any infrared therapy. The investigators hope to reduce the risk of stenosis in the fistula and improve the fistula survival with this treatment. Furthermore, the investigators want to explore the change in several biochemical markers during the treatment with infrared therapy.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of far infrared therapy on arteriovenous fistula maturation, survival and stenosis in hemodialysis patients, a randomized, controlled clinical trial: the FAITH on fistula trial.
Lindhard K, Rix M, Heaf JG, Hansen HP, et al · · 2021 · cited 10× · PMID 34419006 · DOI 10.1186/s12882-021-02476-x -
Cellular and molecular mechanisms underlying hemodialysis arteriovenous fistula dysfunction and approaches to promote maturation: a vascular perspective.
Shiu YT, Northrup H, Huang Y, Cho ME, et al · · 2025 · cited 7× · PMID 40465509 · DOI 10.1152/ajpheart.00010.2025 -
The effect of far infrared radiation on maturation in arteriovenous fistulas in patients on hemodialysis: A randomized controlled, multicenter trial.
Lindhard K, Hansen HP, Gliese K, Hansen E, et al · · 2026 · PMID 41178583 · DOI 10.1177/11297298251385043
Verify or expand the search:
- PubMed search for NCT04011072
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Herlev and Gentofte Hospital trials
Trials by the same sponsor.
- NCT07493590 — CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction · not yet recruiting
- NCT07321964 — The Effect of a Digital MediYoga Program on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fi · NA · recruiting
- NCT06706661 — Implementation of Nutritional Efforts on Discharged Older Patients · NA · recruiting
- NCT06618417 — Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients with · NA · recruiting
- NCT06642272 — A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04011072 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Herlev and Gentofte Hospital
- Last refreshed: 29 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04011072.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing